http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-024918-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7f6e33603375c486b0ab3505830af9e8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C239-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C225-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C239-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-133
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-10
filingDate 2000-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2002-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-024918-A1
titleOfInvention CYCLLOBUTEN DERIVATIVES, ITS PREPARATION AND THERAPEUTIC USES.
abstract Compounds of the formula 1 are described wherein R1 and R2 each represent a variety of organic groups R3 and R4 each represent hydrogen or a variety of organic groups; A represents a group of the formula (A-1): wherein R5 represents hydrogen, hydroxy or alkyl, R6 represents hydroxy, alkoxy, alkylthio, or an amine residue, X and Y each represent oxygen or sulfur, and Z represents a direct individual bond between the nitrogen atom shown and the benzene ring shown in formula 1, or an alkylene group, G represents a single bond, alkylene or substituted alkylene; the dotted line represents a single or double bond, when the dotted line represents a double bond, D represents a carbon atom; and E represents a group = NO-, when the dotted line represents an individual bond, D represents a CH group or a nitrogen atom and E represents an oxygen atom, a sulfur atom, a -NH- group or a -CO group -, and pharmaceutically acceptable salts, esters or other derivatives thereof, which have the ability to inhibit an ileal bile acid transporter and therefore can be used to treat or prevent hypercholesterolemia.
priorityDate 1999-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 73.